NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
50 hedge funds and large institutions have $51M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
13
Reduced
15
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Millennium Management
New York
|
$0 |
2 |
2
Renaissance Technologies
New York
|
$4.23M |
3 |
EI
3
EAM Investors
Solana Beach,
California
|
$0 |
4 |
4
Two Sigma Advisers
New York
|
$0 |
5 |
5
BlackRock
New York
|
$6.88M |